Metraipolis › archive › dc_0293e7efa272

TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer — Europe PMC PMID:42370800

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42370800
DOI
10.18632/oncotarget.28891
License (as archived)
solo-consultazione
Archived
2026-11-01T01:32:11.746Z
SHA-256 of the archived text
4af2cc4e284d99fb80ce1ec2c7ce73135768d54c394b3508b5b485e1f4b01ad2
Stable URL of this page
https://metraipolis.com/documento/dc_0293e7efa272

How to cite

TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer — Europe PMC PMID:42370800 — Europe PMC (en), https://europepmc.org/article/MED/42370800 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0293e7efa272 (Metraipolis archive dc_0293e7efa272, sha256 4af2cc4e284d99fb80ce1ec2c7ce73135768d54c394b3508b5b485e1f4b01ad2)
BibTeX
@misc{dc0293e7efa272,
  title = {TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer — Europe PMC PMID:42370800},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42370800},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0293e7efa272; sha256 4af2cc4e284d99fb80ce1ec2c7ce73135768d54c394b3508b5b485e1f4b01ad2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42370800. Agents can read the archived copy with the MCP tool read_document.